GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Green Valley North, Henderson: Sculpted MD Henderson, Medical Weight Loss & Family Clinic and Nevada Weight Loss Wellness. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Green Valley North, Henderson, without the jargon. Sold as Mounjaro for diabetes and Zepbound for weight loss, tirzepatide stands out for its unique dual-hormone mechanism.
Escalating too fast mainly risks digestive effects; patience during titration usually pays off. Each dose increase is a key moment: that is often when side effects briefly return.
On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. Local landmark: Sculpted MD Henderson (170 S Green Valley Pkwy), rated 4.7/5 across 68 reviews. Tirzepatide belongs to the 'Dual GIP + GLP-1 agonist (first twincretin molecule)' class and is given as a weekly subcutaneous injection. Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Depending on the timing, you resume as soon as possible or wait for the next injection; the clinician adapts, and you never double up without advice.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.